Octagam  10 % 100 mg/ml soluţie perfuzabilă Մոլդովա - ռումիներեն - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

octagam 10 % 100 mg/ml soluţie perfuzabilă

octapharma pharmazeutika produktionsges. m.b.h - immunoglobulinum umane - soluţie perfuzabilă - 100 mg/ml

Imfinzi Եվրոպական Միություն - ռումիներեն - EMA (European Medicines Agency)

imfinzi

astrazeneca ab - durvalumab - carcinom, pulmonar non-celulă mică - agenți antineoplazici - non-small cell lung cancer (nsclc)imfinzi as monotherapy is indicated for the treatment of locally advanced, unresectable non small cell lung cancer (nsclc) in adults whose tumours express pd-l1 on ≥ 1% of tumour cells and whose disease has not progressed following platinum based chemoradiation therapy (see section 5. imfinzi in combination with tremelimumab and platinum-based chemotherapy is indicated for the first-line treatment of adults with metastatic nsclc with no sensitising egfr mutations or alk positive mutations. small cell lung cancer (sclc)imfinzi in combination with etoposide and either carboplatin or cisplatin is indicated for the first-line treatment of adults with extensive-stage small cell lung cancer (es-sclc). biliary tract cancer (btc)imfinzi in combination with gemcitabine and cisplatin is indicated for the first line treatment of adults with unresectable or metastatic biliary tract cancer (btc). hepatocellular carcinoma (hcc)imfinzi in combination with tremelimumab is indicated for the first line treatment of adults with advanced or unresectable hepatocellular carcinoma (hcc).

Flucelvax Tetra Եվրոպական Միություն - ռումիներեն - EMA (European Medicines Agency)

flucelvax tetra

seqirus netherlands b.v. - a/darwin/6/2021(h3n2)-like strain (a/darwin/11/2021, wild type) / a/wisconsin/67/2022 (h1n1)pdm09-like strain (a/georgia/12/2022 cvr-167) / b/austria/1359417/2021-like strain (b/singapore/wuh4618/2021) / b/phuket/3073/2013-like virus (b/singapore/inftt-16-0610/2016, wild type) - gripa, umană - gripa, cu virus inactivat, split virusului sau antigenului de suprafață al - prophylaxis of influenza in adults and children from 2 years of age. flucelvax tetra ar trebui să fie utilizate în conformitate cu recomandările oficiale.

FSME-IMMUN 0,25 ml JUNIOR Ռումինիա - ռումիներեն - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

fsme-immun 0,25 ml junior

pfizer manufacturing belgium nv - belgia - vaccin impotriva encefalitei de capuse - susp. inj. in seringa preumpluta - 0,25ml - vaccinuri virale vaccinuri contra encefalitei

OCTAGAM 50 mg/ml Ռումինիա - ռումիներեն - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

octagam 50 mg/ml

octapharma pharmazeutika produktionsges.m.b.h. - austria - imunoglobulina normala pt. adm. intravasculara - sol. perf. - 50mg/ml - imunoglobuline imunoglobulina umana de origine umana

OCTAGAM 10% Ռումինիա - ռումիներեն - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

octagam 10%

octapharma pharmazeutika produktionsges m.b.h. - austria - imunoglobulina normala pt. adm. intravasculara - sol. perf. - 100 mg/ml - imunoglobuline imunoglobulina umana de origine umana

BOOSTRIX Ռումինիա - ռումիներեն - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

boostrix

glaxosmithkline biologicals sa - belgia - vaccin difteric,tetanic,pertussis - susp. inj. in seringa preumpluta - vaccinuri bacteriene vaccinuri pertussis

Octagam  10 % 100 mg/ml soluţie perfuzabilă Մոլդովա - ռումիներեն - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

octagam 10 % 100 mg/ml soluţie perfuzabilă

octapharma pharmazeutika produktionsges. m.b.h - immunoglobulinum umane - soluţie perfuzabilă - 100 mg/ml